Canopy Growth (NASDAQ:CGC - Get Free Report) is set to announce its earnings results before the market opens on Friday, November 8th. Analysts expect the company to announce earnings of ($0.38) per share for the quarter. Parties that are interested in participating in the company's conference call can do so using this link.
Canopy Growth (NASDAQ:CGC - Get Free Report) last announced its quarterly earnings results on Friday, August 9th. The company reported ($0.37) earnings per share for the quarter, missing analysts' consensus estimates of ($0.31) by ($0.06). Canopy Growth had a negative return on equity of 73.30% and a negative net margin of 240.19%. The business had revenue of $48.39 million for the quarter, compared to analysts' expectations of $51.82 million. On average, analysts expect Canopy Growth to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Canopy Growth Stock Up 5.9 %
NASDAQ:CGC traded up $0.27 during mid-day trading on Friday, hitting $4.86. The company had a trading volume of 4,473,259 shares, compared to its average volume of 7,685,799. Canopy Growth has a 1 year low of $2.76 and a 1 year high of $14.92. The business has a fifty day simple moving average of $4.73 and a 200-day simple moving average of $6.73. The company has a current ratio of 2.15, a quick ratio of 1.64 and a debt-to-equity ratio of 1.05. The firm has a market capitalization of $456.16 million, a price-to-earnings ratio of -0.69 and a beta of 0.86.
Analyst Ratings Changes
Separately, Piper Sandler reduced their price target on Canopy Growth from $3.00 to $2.00 and set an "underweight" rating for the company in a report on Tuesday, July 9th.
Read Our Latest Report on CGC
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
See Also
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
